C P Quinn
Overview
Explore the profile of C P Quinn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stark G, Sivko G, VanRaden M, Schiffer J, Taylor K, Hewitt J, et al.
Vaccine
. 2016 Aug;
34(51):6512-6517.
PMID: 27558619
Anthrax vaccine adsorbed (AVA, BioThrax) was recently approved by the Food and Drug Administration (FDA) for a post-exposure prophylaxis (PEP) indication in adults 18-65years of age. The schedule is three...
2.
Sivko G, Stark G, Tordoff K, Taylor K, Glaze E, VanRaden M, et al.
Vaccine
. 2016 May;
34(51):6518-6528.
PMID: 27155494
Anthrax Vaccine Adsorbed (AVA, BioThrax) is approved by the US Food and Drug Administration for post-exposure prophylaxis (PEP) of anthrax in adults. The PEP schedule is 3 subcutaneous (SC) doses...
3.
SEMENOVA V, Schiffer J, Steward-Clark E, Soroka S, Schmidt D, Brawner M, et al.
J Immunol Methods
. 2011 Dec;
376(1-2):97-107.
PMID: 22197974
Accurate, reliable and standardized quantification of anti-protective antigen (PA) IgG antibody levels is essential for comparative analyses of anti-toxin immune responses in anthrax cases, recipients of PA-based anthrax vaccines and...
4.
Tondella M, Carlone G, Messonnier N, Quinn C, Meade B, Burns D, et al.
Vaccine
. 2008 Dec;
27(6):803-14.
PMID: 19071179
An international meeting on Bordetella pertussis assay standardization and harmonization was held at the Centers for Disease Control and Prevention (CDC), Atlanta, GA, 19-20 July 2007. The goal of the...
5.
SEMENOVA V, Schmidt D, Taylor Jr T, Li H, Steward-Clark E, Soroka S, et al.
Vaccine
. 2007 Jan;
25(10):1780-8.
PMID: 17229495
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax) injections were determined in a cross-sectional study of...
6.
Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax
Williamson E, Hodgson I, Walker N, Topping A, Duchars M, Mott J, et al.
Infect Immun
. 2005 Aug;
73(9):5978-87.
PMID: 16113318
Immunization with a recombinant form of the protective antigen (rPA) from Bacillus anthracis has been carried out with rhesus macaques. Rhesus macaques immunized with 25 mug or more of B....
7.
Biagini R, Sammons D, Smith J, MacKenzie B, Striley C, Robertson S, et al.
Anal Bioanal Chem
. 2005 Jun;
382(4):1027-34.
PMID: 15931499
Select Agents are defined by CDC and the USDA Animal and Plant Health Inspection Service (APHIS) as biological agents or toxins deemed a threat to public, animal, or plant health,...
8.
SEMENOVA V, Steward-Clark E, Stamey K, Taylor Jr T, Schmidt D, Martin S, et al.
Clin Diagn Lab Immunol
. 2004 Sep;
11(5):919-23.
PMID: 15358653
An anti-Anthrax Vaccine Adsorbed (anti-AVA) standard human reference serum pool, AVR414, has been prepared, and the total and protective antigen (PA)-specific immunoglobulin G (IgG) were quantified. AVR414 was prepared by...
9.
Hallis B, Silman N, Noonan S, Baker R, Roberts A, Quinn C, et al.
Dev Biol (Basel)
. 2003 Apr;
111:321-6.
PMID: 12678256
The characterisation and evaluation of the UK licensed human anthrax vaccine depends on several in vivo tests that determine its safety and potency. Assays for the determination of functionally active...
10.
JERNIGAN J, Stephens D, Ashford D, Omenaca C, Topiel M, Galbraith M, et al.
Emerg Infect Dis
. 2001 Dec;
7(6):933-44.
PMID: 11747719
From October 4 to November 2, 2001, the first 10 confirmed cases of inhalational anthrax caused by intentional release of Bacillus anthracis were identified in the United States. Epidemiologic investigation...